4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-002840
Chief Scientific Officer gave up 2,583 shares (to pay taxes)
- Chief Scientific Officer acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2024-02-01 | Option exercise | +7,500 | 137,224 | D | ||
| Monahan Joseph Chief Scientific Officer | 2024-02-01 | Shares withheld for taxes | −2,583 | $1.20 | $3,100 | 134,641 | D |
| Derivatives | |||||||
| Monahan Joseph Chief Scientific Officer | 2024-02-01 | Option exercise · Restricted Stock Unit | −7,500 | 22,500 | D | ||
| Monahan Joseph Chief Scientific Officer | 2024-02-01 | Grant or award · Employee Stock Option (Right to Buy) | +206,500 | 206,500 | D | ||
| Monahan Joseph Chief Scientific Officer | 2024-02-01 | Grant or award · Restricted Stock Units | +59,000 | 59,000 | D | ||
| Monahan Joseph Chief Scientific Officer | 2024-02-01 | Grant or award · Restricted Stock Units | +147,500 | 147,500 | D | ||
Loading xslF345X05/doc4.xml…